PASITHEA THERAPEUTICS CORP. (KTTA) Free cash flow 2022–2024
PASITHEA THERAPEUTICS CORP. (KTTA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.0MFY2024 · since FY2022: -$14.6M → -$14.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$14.0M | -8.0% |
| FY2023 | -$12.9M | +11.4% |
| FY2022 | -$14.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KTTA financial trends
KTTA RevenueKTTA Net incomeKTTA Net marginKTTA Gross profitKTTA Gross marginKTTA Operating incomeKTTA Operating marginKTTA Operating cash flowKTTA Capital expendituresKTTA Return on equityKTTA Stock buybacksKTTA Dividends paidKTTA Total assetsKTTA Total liabilitiesKTTA Shareholders’ equityKTTA overview →